Form 6-K NOVARTIS AG For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
Novartis (NVS) Reports In-Line Q3 EPS of $1.21; Guides FY15 Sales Growth
January 27, 2015 7:47 AM ESTNovartis (NYSE: NVS) reported Q3 EPS of $1.21, in-line with the analyst estimate of $1.21. Revenue for the quarter came in at $14.63 billion versus the consensus estimate of $14.68 billion.
Strong innovation momentum continues from... More


